Christopher William Schultz, PhD
Educational Background
PostDoc, National Cancer Institute, 2025
PhD, Genetics, Genomics and Biology of Cancer, Thomas Jefferson University, 2020
BS, Chemistry, Drexel University 2015
Memberships
AACR Membership
Honors & Awards
K99/R00 2023-Present
FARE travel award NIH – competitive travel award 2022
NCI Graduate Student Recruitment Program – Competitive program recruiting graduate students to become fellows at the NCI 2019
Lab Overview
The Schultz lab aims to further understand small cell lung cancer and unique vulnerabilities associated with neuroendocrine differentiation and characteristic mutations present in small cell lung cancer. All work at the Schultz lab is designed to be translationally relevant, with every project aimed at near-term translatability to the clinic if successful.
Selected Publications
https://orcid.org/0000-0001-5731-2847
Additional Publications
1)Schultz CW et al ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer, PMID:37491889, 2023, EMBO Molecular Medicine
2)Lorinc S Pongor, Schultz CW et al… Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes, PMID: 36715552, 2023, Cancer Discovery
3) Schultz CW et al The FDA approved anthelmintic Pyrvinium Pamoate inhibits pancreatic adenocarcinoma through inhibiting HuR and mitochondrial survival pathways, PMID: 34413127, 2021, Molecular Cancer Therapeutics